ACUTA CAPITAL PARTNERS, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$71.6B
Holdings
28
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OCULOCULAR THERAPEUTIX INC | 1,014,940 | $9.4B | 13.15% | |
| 2 | CDTXCIDARA THERAPEUTICS INC | 179,569 | $8.7B | 12.21% | |
| 3 | WHWKWHITEHAWK THERAPEUTICS INC | 3,410,402 | $6.4B | 8.90% | |
| 4 | SLNOSOLENO THERAPEUTICS INC | 63,436 | $5.3B | 7.42% | |
| 5 | TRMLTOURMALINE BIO INC | 283,682 | $4.5B | 6.33% | |
| 6 | ASNDASCENDIS PHA-ADR | 22,576 | $3.9B | 5.44% | |
| 7 | IM8NINSMED INC | 37,070 | $3.7B | 5.21% | |
| 8 | ARGXARGEN SE - ADR | 6,702 | $3.7B | 5.16% | |
| 9 | PRAXPRAXIS PRECISION MEDICINES I | 74,087 | $3.1B | 4.35% | |
| 10 | JAZZJAZZ PHARMACEUTICALS PLC | 26,283 | $2.8B | 3.89% | |
| 11 | TRVITREVI THERAPEUTICS INC | 493,735 | $2.7B | 3.77% | |
| 12 | OCSOCULIS HOLDING AG | 106,718 | $2.1B | 2.89% | |
| 13 | RVMDREVOLUTION MEDICINES INC | 55,693 | $2.0B | 2.86% | |
| 14 | HLXCHELIX ACQUISITION CORP II | 187,257 | $2.0B | 2.78% | |
| 15 | TERNTERNS PHARMACEUTICALS INC | 463,864 | $1.7B | 2.42% | |
| 16 | SRZNSURROZEN, INC. | 170,000 | $1.5B | 2.12% | |
| 17 | DRUGBRIGHT MINDS BIOSCIENCES INC | 48,474 | $1.3B | 1.77% | |
| 18 | TSHATAYSHA GENE THERAPIES INC | 485,669 | $1.1B | 1.57% | |
| 19 | AKROAKERO THERAPEUTICS INC | 19,772 | $1.1B | 1.47% | |
| 20 | ZYMEZYMEWORKS INC | 83,655 | $1.0B | 1.47% | |
| 21 | LQDALIQUIDIA CORPORATION | 75,876 | $945.4M | 1.32% | |
| 22 | RAREULTRAGENYX PHARMACEUTICAL INC | 23,814 | $865.9M | 1.21% | |
| 23 | VSTMVERASTEM INC | 150,414 | $624.2M | 0.87% | |
| 24 | FULCFULCRUM THERAPEUTICS INC | 59,650 | $410.4M | 0.57% | |
| 25 | UNCYUNICYCIVE THERAPEUTICS INC | 62,899 | $300.0M | 0.42% | |
| 26 | RAPPRAPPORT THERAPEUTICS INC | 20,000 | $227.4M | 0.32% | |
| 27 | ARTVARTIVA BIOTHERAPEUTICS INC | 45,456 | $68.6M | 0.10% | |
| 28 | NUVB/WSNUVATION BIO INC -CW27 | 90,832 | $24.5M | 0.03% |